Robin Guelimi
YOU?
Author Swipe
View article: Effect of methodological choices and inclusion criteria on network meta-analysis results in psoriasis
Effect of methodological choices and inclusion criteria on network meta-analysis results in psoriasis Open
We found that different methodological choices could influence NMAs' results. However, even though moderate variation in effect estimates could be observed across the analyses, treatment hierarchies remained stable for the top-ranking drug…
View article: Serious adverse events associated with systemic treatments for psoriasis: a network meta-analysis of observational studies and randomized controlled trials
Serious adverse events associated with systemic treatments for psoriasis: a network meta-analysis of observational studies and randomized controlled trials Open
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the safety of current systemic treatments for moderate‐to‐severe psoriasis in adults, using a network meta‐analysis that includes both random…
View article: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Open
Our review shows that, compared to placebo, the biologics infliximab, bimekizumab, ixekizumab, and risankizumab were the most effective treatments for achieving PASI 90 in people with moderate-to-severe psoriasis on the basis of high-certa…
View article: Network meta‐analysis: methodological points for readers, authors and reviewers
Network meta‐analysis: methodological points for readers, authors and reviewers Open
International audience
View article: Overlapping network meta‐analyses on psoriasis systemic treatments, an overview: quantity does not make quality
Overlapping network meta‐analyses on psoriasis systemic treatments, an overview: quantity does not make quality Open
In addition to a duplication of efforts, our overview showed heterogeneous methods and poor confidence in the results in a majority of the included NMAs, further distorted by reporting issues and spin. Clinicians need to interpret NMAs wit…
View article: Non‐acral skin manifestations during the COVID‐19 epidemic: COVIDSKIN study by the French Society of Dermatology
Non‐acral skin manifestations during the COVID‐19 epidemic: COVIDSKIN study by the French Society of Dermatology Open
A variety of skin manifestations occurring during the COVID-19 pandemic have been reported since March 2020.1 The most reported were chilblain-like lesions, widespread urticaria, maculopapular eruptions, vesicular eruptions and vascular le…
View article: Manifestations cutanées au cours l’épidémie de COVID-19 : étude COVID-Skin de la Société française de dermatologie
Manifestations cutanées au cours l’épidémie de COVID-19 : étude COVID-Skin de la Société française de dermatologie Open